06/05/2025 3:57 PM | Clearmind Medicine (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/12/2025 8:02 AM | Clearmind Medicine (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/25/2025 7:05 AM | Clearmind Medicine (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/23/2025 7:27 AM | Clearmind Medicine (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/17/2025 6:41 AM | Clearmind Medicine (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/10/2025 7:27 AM | Clearmind Medicine (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2025 5:56 AM | Clearmind Medicine (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/24/2025 5:05 AM | Clearmind Medicine (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/17/2025 11:15 PM | Clearmind Medicine (Filer)
| Form EFFECT | |
02/18/2025 11:15 PM | Clearmind Medicine (Filer)
| Form EFFECT | |
02/14/2025 12:27 PM | Clearmind Medicine (Subject) Iroquois Capital Management, LLC (Filed by)
| Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for CMND and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Clearmind Medicine and its competitors with MarketBeat's FREE daily newsletter.
|
02/04/2025 3:01 PM | Clearmind Medicine (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/22/2025 3:30 PM | Clearmind Medicine (Filer)
| Form POS AM | |
01/07/2025 3:00 PM | Clearmind Medicine (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/09/2024 4:12 PM | Clearmind Medicine (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/06/2024 4:00 PM | Clearmind Medicine (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/30/2024 11:15 PM | Clearmind Medicine (Filer)
| Form EFFECT | |
09/24/2024 3:30 PM | Clearmind Medicine (Filer)
| Form POS AM | |
09/12/2024 3:01 PM | Clearmind Medicine (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/29/2024 3:30 PM | Clearmind Medicine (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/20/2024 3:15 PM | Clearmind Medicine (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/30/2024 11:15 PM | Clearmind Medicine (Filer)
| Form EFFECT | |
07/23/2024 3:15 PM | Clearmind Medicine (Filer)
| Form POS AM | |
06/13/2024 3:01 PM | Clearmind Medicine (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/13/2024 3:01 PM | Clearmind Medicine (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |